With the advent of the era of high‐throughput sequencing and precision medicine of AL, genetic mutations of IKZF1 were firstly reported in aggressive B‐ALL subtypes, that is, BCR::ABL1/‐like, which were characterised by the high relapse rate and short survival duration.8, 16, 25. This evidence concerns the gene BCR and acute lymphoblastic leukemia.